# Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

> **NCT05012631** · PHASE2 · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 24 (estimated)

## Conditions studied

- Sickle Cell Disease
- Diffuse Myocardial Fibrosis

## Interventions

- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT05012631
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05012631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05012631, "Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05012631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*